These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28 related articles for article (PubMed ID: 1537769)
1. Cough as a neurological sign: What a clinician should know. Al-Biltagi M; Bediwy AS; Saeed NK World J Crit Care Med; 2022 May; 11(3):115-128. PubMed ID: 36331984 [TBL] [Abstract][Full Text] [Related]
2. Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance. Walker AJ; Price JB; Borreggine K; Sutor SL; Gogos A; McGillivray JA; Frye MA; Tye SJ Transl Psychiatry; 2019 Mar; 9(1):113. PubMed ID: 30877268 [TBL] [Abstract][Full Text] [Related]
3. Major depressive disorder in children and adolescents. Mullen S Ment Health Clin; 2018 Nov; 8(6):275-283. PubMed ID: 30397569 [TBL] [Abstract][Full Text] [Related]
4. Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review. Pisano S; Pozzi M; Catone G; Scrinzi G; Clementi E; Coppola G; Milone A; Bravaccio C; Santosh P; Masi G Curr Neuropharmacol; 2019; 17(4):318-341. PubMed ID: 29256353 [TBL] [Abstract][Full Text] [Related]
5. Systematic review of management for treatment-resistant depression in adolescents. Zhou X; Michael KD; Liu Y; Del Giovane C; Qin B; Cohen D; Gentile S; Xie P BMC Psychiatry; 2014 Nov; 14():340. PubMed ID: 25433401 [TBL] [Abstract][Full Text] [Related]
6. The use of cognitive behavioral therapy in the treatment of resistant depression in adolescents. Hamill-Skoch S; Hicks P; Prieto-Hicks X Adolesc Health Med Ther; 2012; 3():95-104. PubMed ID: 24600290 [TBL] [Abstract][Full Text] [Related]
7. Psychopharmacologic treatment of pediatric major depressive disorder. Boylan K; Romero S; Birmaher B Psychopharmacology (Berl); 2007 Mar; 191(1):27-38. PubMed ID: 16896960 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of dysthymia in children and adolescents. Nobile M; Cataldo GM; Marino C; Molteni M CNS Drugs; 2003; 17(13):927-46. PubMed ID: 14533944 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment of depression in children and adolescents. Findling RL; Reed MD; Blumer JL Paediatr Drugs; 1999; 1(3):161-82. PubMed ID: 10937449 [TBL] [Abstract][Full Text] [Related]
10. A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents. Renaud J; Axelson D; Birmaher B Drug Saf; 1999 Jan; 20(1):59-75. PubMed ID: 9935277 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of a refractory depressive episode]. Bougerol T Encephale; 1993 Aug; 19 Spec No 3():459-66. PubMed ID: 8299544 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacological treatment of delusional depression]. Amore M; Giordani L; Giorgetti G; Zazzeri N Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200 [TBL] [Abstract][Full Text] [Related]
14. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. Strober M; Freeman R; Rigali J; Schmidt S; Diamond R J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):16-20. PubMed ID: 1537769 [TBL] [Abstract][Full Text] [Related]
15. Treatment of imipramine-resistant recurrent depression: II. An open clinical trial of lithium augmentation. Thase ME; Kupfer DJ; Frank E; Jarrett DB J Clin Psychiatry; 1989 Nov; 50(11):413-7. PubMed ID: 2509437 [TBL] [Abstract][Full Text] [Related]